Myristoyl Pentapeptide-17
Overview
Myristoyl Pentapeptide-17 is a lipopeptide composed of a pentapeptide sequence conjugated to myristic acid to facilitate penetration of the hair follicle and dermal layers. It is marketed primarily for enhancement of eyelash and eyebrow growth through proposed stimulation of keratin gene expression and prolongation of the anagen phase of the hair cycle.
Mechanism of Action
The peptide is intended for cosmetic applications related to hair conditioning and growth.
Research Summary & Key Findings
Preclinical keratinocyte culture studies have suggested increased keratin synthesis, and small consumer studies have reported subjective improvements in eyelash length and thickness. No randomized, placebo-controlled trials have been published in peer-reviewed ophthalmology or dermatology journals, and the peptide lacks regulatory approval for hair growth indications.
Clinical Status
Myristoyl Pentapeptide-17 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
References
Primary literature
- PubMed — "Myristoyl Pentapeptide-17"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Myristoyl Pentapeptide-17"
Registered interventional and observational studies, including status and phase.
- PubChem — "Myristoyl Pentapeptide-17"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Dermatology
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine a...
View detailsArgireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter...
View detailsMatrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety t...
View detailsMatrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapept...
View detailsStart Your Consultation
Get an AI-proposed Myristoyl Pentapeptide-17 protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Myristoyl Pentapeptide-17.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.